UCLA study: COVID vaccinations may lessen severe kidney damage
UCLA Health researchers found 16% of unvaccinated patients were more likely to need a constant dialysis therapy, compared with 11% of vaccinated patients.
The study data came from roughly 3,500 patients admitted to hospitals between March 2020 and March 2022.
Study lead author and UCLA nephrology professor Dr. Niloofar Nobakht said the continuous renal replacement therapy (CRRT) form of dialysis is vital for intensive care patients with damaged kidneys.
The goal of the study was to asses the severity of kidney injury in COVID patients needing CRRT while hospitalized.
According to University of Pennsylvania biostatistics professor Yong Chen, serious kidney complications are typically associated with severe COVID cases.
Study participants had received at least two doses of the Pfizer or Moderna mRNA vaccines or one dose of the Johnson & Johnson Janssen vaccine.
Yale University Dr. F. Perry Wilson said the main reason vaccinated people have lower kidney injury rates is the vaccines tend to lessen the chances of severe illness.
He said the vaccines don't act directly on the kidneys but instead reduce overall illness severity, which in turn helps to prevent complications such as multi-organ failure.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
7 hours ago
- CBS News
Pfizer CEO attending $25 million fundraiser at Trump's golf club after president demands drug price cuts, sources say
Pfizer CEO Albert Bourla is among those expected at a fundraiser President Trump is attending Friday at his golf club in Bedminster, New Jersey, sources told CBS News. The fundraiser for the pro-Trump super political action committee MAGA Inc. aims to raise about $25 million, one of the sources said. One day prior to the event, Mr. Trump sent letters to pharmaceutical companies, including Pfizer, demanding they lower U.S. drug prices to more evenly match what other countries pay. The White House's letters to 17 drug companies, including AstraZeneca, Bristol Myers Squibb, Eli Lilly, Johnson & Johnson and Sanofi, asked for commitments within 60 days to sell drugs for Medicaid patients and all new drugs at "most favored nation" rates. The president posted images of the letters to Truth Social. Mr. Trump signed an executive order in May telling federal officials to draw up "most favored nation" regulations unless pharmaceutical companies made progress toward cutting prices. This week's letters — which were addressed to Bourla and the other CEOs — accused the drugmakers of promising "more of the same" since then. The president said Friday he's "gone to war with the drug companies and, frankly, other countries" on the drug price issue. "I think we're going to be very successful fairly soon. We'll have drug prices coming down by 500, 600 800 even 1,200 percent," Mr. Trump said in an interview with Newsmax on Friday afternoon. The high cost of prescription drugs has vexed both parties for decades. Proposals to tie drug prices for U.S. patients to the typically much-lower rates charged in other developed countries have floated around for years, but the idea has faced some legal pushback. Meanwhile, drugmakers argue price caps could discourage innovation by making it harder to pay for research and development for new drugs. The industry also argues that Americans tend to have access to more groundbreaking drugs than residents of foreign countries with stricter price regulations — and says high drug prices are just one part of a broader trend of higher healthcare spending in the U.S. Bourla has engaged with Mr. Trump in the past. Pfizer was one of the drugmakers that was picked to rapidly develop COVID-19 vaccines in the first Trump administration's "Operation Warp Speed." And two weeks before Mr. Trump's second inauguration, Bourla and other Pfizer executives traveled to Mar-A-Lago for meetings, the Financial Times has previously reported. CBS News has reached out to Pfizer and the White House for comment.
The Hill
10 hours ago
- The Hill
CDC bars expert groups from advising on vaccines
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story CDC bars expert groups from advising on vaccines The Centers for Disease Control and Prevention (CDC) told some expert groups that they will no longer be able to help review scientific data used to issue vaccine recommendations. © APSome members of the Advisory Committee on Immunization Practice's (ACIP) working groups, including physician groups and infectious disease specialists, were sent e-mails late Thursday notifying them that they will no longer serve on the subcommittees. The groups were removed from the subcommittees because they were deemed biased by the Trump administration, according to a copy of the email shared with The Hill. "By definition, Liason organizations are special interest groups and therefore are expected to have a 'bias' based on their constituency/and or population that they represent," the email reads. "It is important that the ACIP Workgroup activities remain free of influence from any special interest groups so ACIP workgroups will no longer include Liason organizations." Eight of the advisory groups released a joint statement Friday saying they are 'deeply disappointed' that they are now barred from informing the development of vaccine recommendations. 'For decades liaisons from our organizations have reviewed published and unpublished data and literature related to vaccine efficacy, effectiveness, and safety and provided unbiased input for ACIP's consideration,' the statement reads. 'To remove our deep medical expertise from this vital and once transparent process is irresponsible, dangerous to our nation's health, and will further undermine public and clinician trust in vaccines.' The groups, which include the American Medical Association, as well as the Infectious Diseases Society of America, called on the Trump administration to reconsider their exclusion from the vaccine review process. A spokesperson for the Department of Health and Human Services (HHS), which oversees the CDC, said that experts will continue to be included in the review process based on 'relevant experience and expertise." 'Under the old ACIP, outside pressure to align with vaccine orthodoxy limited asking the hard questions,' the spokesperson wrote. 'The old ACIP members were plagued by conflicts of interest, influence and bias.' The notice is the latest move from the Trump administration to shake up the nation's vaccine policy and is another major change to the CDC's advisory panel on vaccines. HHS Secretary Robert F. Kennedy Jr abruptly fired all 17 sitting members of ACIP in early June, accusing them of having conflicts of interest and rubber-stamping decisions related to the COVID-19 vaccine. He then replaced the panel with eight hand-picked appointees, including some vaccine skeptics. Welcome to The Hill's Health Care newsletter, we're Nathaniel Weixel, Alejandra O'Connell-Domenech — every week we follow the latest moves on how Washington impacts your health. Did someone forward you this newsletter? Subscribe here. Essential Reads How policy will be impacting the health care sector this week and beyond: Most adults do not plan on getting COVID-19 shot amid vaccine policy changesMore than half of American adults — 59 percent — say they do not expect to get the COVID-19 booster shot this autumn, according to new poll findings from health care policy group KFF. Poll results show 23 percent of U.S. adult respondents said they will 'probably not' get the vaccine, while 37 percent said they will 'definitely not' get the shot. Americans who said they will 'probably' or 'definitely' not get the shot were … Full Story Blue states challenge Trump's restrictions on gender-affirming care More than a dozen Democratic attorneys general announced a lawsuit challenging recent moves by President Trump's administration to severely restrict access to gender-affirming health care for anyone under 19, including in states where treatment is legal and protected by law. Full Story Fired vaccine board members warn of fallout from RFK Jr. policiesRecently removed members of a Centers for Disease Control and Prevention (CDC) vaccine advisory panel warn that Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.'s move to replace them shows he is 'abandoning' rigorous scientific review and open deliberation. Kennedy fired all 17 sitting members of the Advisory Committee on Immunization Practices (ACIP) in early June, accusing members of having conflicts of … Full Story In Other News Branch out with a different read: Number of Texans receiving out-of-state abortions quadrupled between 2021 and 2023 AUSTIN (KXAN) — Texans who sought an abortion out of state more than quadrupled between 2021 and 2023 after a state law went into effect that bans the procedure in almost all cases. Data from the Texas Health and Human Services Commission (HHSC) shows at least 7,844 Texas residents received an abortion in a different state in 2023, up from 4,718 in 2022 and 1,712 in 2021. Still the total number of abortions for Texas residents … Full Story Around the Nation Local and state headlines on health care:More than 2,000 DACA recipients in California to lose health insurance (the San Francisco Chronicle) Some rural Texas seen THC as a lifeline for their health and economy (The Texas Tribune) Illinois becomes first state to require mental health screenings for students (ABC) What We're Reading Health news we've flagged from other outlets: Medicare, Medicaid plans to experiment with covering weight loss drugs (The Washington Post) Wildfire smoke and unhealthy air fill the Midwest before spreading to the East (The Washington Post) Remember running a mile in school? The Presidential Fitness Test is coming back (NPR) You're all caught up. See you next week! Close Thank you for signing up! Subscribe to more newsletters here The latest in politics and policy. Direct to your inbox. Sign up for the Health Care newsletter Subscribe
Epoch Times
10 hours ago
- Epoch Times
Most Americans Won't Get COVID-19 Booster This Fall, Survey Says
A majority of Americans said they will likely not receive a COVID-19 booster vaccine this fall, according to a poll released Friday. A survey from the health care organization KFF found that 59 percent of respondents said they either will not or likely will not receive the booster dose. Around 37 percent said they would 'definitely not' receive the shot, while 23 percent said they would 'probably not get' the shot.
